Black Rock Inc. Seres Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 6,825,399 shares of MCRB stock, worth $5.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,825,399

Previous 7,339,454 7.0%

Holding current value

$5.12 Million

Previous $10.3 Million 48.86%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.75 - $1.56 $385,541 - $801,925	-514,055 Reduced 7.0%	6,825,399 $5.26 Million
Q4 2023 Feb 13, 2024	SELL	$0.93 - $2.15 $541,700 - $1.25 Million	-582,474 Reduced 7.35%	7,339,454 $10.3 Million
Q3 2023 Nov 13, 2023	BUY	$2.33 - $5.07 $1.03 Million - $2.23 Million	440,701 Added 5.89%	7,921,928 $18.9 Million
Q2 2023 Aug 11, 2023	BUY	$4.67 - $6.55 $5.75 Million - $8.07 Million	1,232,141 Added 19.72%	7,481,227 $35.8 Million
Q1 2023 May 12, 2023	SELL	$4.95 - $6.09 $1.04 Million - $1.28 Million	-209,888 Reduced 3.25%	6,249,086 $35.4 Million

Q4 2022 Feb 13, 2023	BUY	$5.09 - $9.05 $807,396 - $1.44 Million	158,624 Added 2.52%	6,458,974 $36.2 Million
Q3 2022 Nov 14, 2022	BUY	$3.5 - $7.2 $1.89 Million - $3.89 Million	539,617 Added 9.37%	6,300,350 $40.5 Million
Q2 2022 Aug 12, 2022	SELL	$2.7 - $7.62 $360,981 - $1.02 Million	-133,697 Reduced 2.27%	5,760,733 $19.8 Million
Q1 2022 May 12, 2022	BUY	$6.3 - $8.84 $199,955 - $280,572	31,739 Added 0.54%	5,894,430 $42 Million
Q4 2021 Feb 10, 2022	BUY	$6.02 - $11.43 $119,701 - $227,274	19,884 Added 0.34%	5,862,691 $48.8 Million
Q3 2021 Nov 09, 2021	SELL	$5.46 - $22.6 $3.16 Million - $13.1 Million	-578,178 Reduced 9.0%	5,842,807 $40.7 Million
Q2 2021 Aug 11, 2021	BUY	$18.46 - $24.36 $119 Million - $156 Million	6,420,985 New	6,420,985 $153 Million

Others Institutions Holding MCRB

# of Institutions

100

Shares Held

62.7M

Call Options Held

36.9K

Put Options Held

476K

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $93.1M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account